Content matching 'personalized medicine'
Researchers received the go-ahead from the FDA to test a gene-editing technique in humans and produce a "functional cure" for HIV.
Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations”
Smoothing the road to the clinic by optimizing your cell culture: an interview with David Fiorentini
Webinar Q and A transcription: ‘Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial’
Reducing stem cell variability with automation for standardized treatments: an interview with NYSCF's Scott Noggle